i was reading that myself this afternoonmy view is that these options vary according to the condition of the company, be it split of sold.it all reads texon mark II awaits
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025